Event Date/Time: Mar 13, 2006
End Date/Time: Mar 14, 2006
The number of regulations and guidances that now impact pharmaceutical companies is daunting. Judging whether a company is behaving in a compliant manner depends on the regulations themselves and the people being asked. New industry guidances, complex rules and regulations, increased regulatory scrutiny, and heightened competition are impacting marketing strategies on a number of levels. In addition, time, money, and resource prioritization coupled with multiple stakeholders who have different, and often conflicting, needs are the barriers the industry faces in terms of becoming more compliant.There has to be a balance between allowing industry to do what it does best-treating and curing disease – and ensuring responsible practice in communicating the results.